GEHC News

AI in Oncology for Analytical Solutions Market to Triple in Size During 2026-2030 Registering 34.2% CAGR - IBM Watson Health, NVIDIA Corp., and Siemens Healthineers Dominate the $1.93 Billion Industry

Artificial Intelligence in Oncology: Assessment of Market Opportunities by Region and Market, 2026-2030 - North America Leads but Asia-Pacific is Emerging Fast

Oncology Devices: Markets and Companies Analysis Report 2026 - Eckert & Ziegler BEBIG, Oncura, GE Healthcare Lead the $210 Billion Industry; Expected to Reach $397 Billion by 2030

Mammography Devices Market to Reach $3.81 Billion by 2030, Driven by Technological Advancements and Rising Breast Cancer Awareness

Radiation Oncology Market Outlook Report 2026-2030: Industry Anticipated to Reach $13.5 Billion by 2030

How Decentralized AI is Unlocking Value in Cardiac Diagnostics

Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures

GE HealthCare annonce qu’elle va jouer un rôle de premier plan au sein du plus grand consortium de l’IHI financé par l’UE visant à faire progresser les soins cardio-oncologiques à travers l’Europe

Riassunto: GE HealthCare annuncia che rivestirà un ruolo industriale leader nel più grande consorzio IHI finanziato dall'UE per la promozione delle cure in ambito cardio-oncologico in Europa

GE HealthCare verkündet leitende industrielle Rolle im größten von der EU finanzierten IHI-Konsortium zur Förderung der kardio‑onkologischen Versorgung in Europa